Anesthetic considerations in pediatric mastocytosis: a review (Q38081373)

28 August 2017

title

Anesthetic considerations in pediatric mastocytosis: a review (English)

1 reference

28 August 2017

Norma J Klein

1

1 reference

28 August 2017

Shad Misseldine

series ordinal

2

1 reference

28 August 2017

publication date

14 February 2013

1 reference

28 August 2017

published in

Journal of Anesthesia

1 reference

28 August 2017

volume

27

1 reference

28 August 2017

issue

4

1 reference

28 August 2017

page(s)

588-598

1 reference

Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Case-control cohort study of patients' perceptions of disability in mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Urticaria pigmentosa: an anesthetic challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Pediatric mastocytosis: routine anesthetic management for a complex disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Recurrent syncope and anaphylaxis as presentation of systemic mastocytosis in a pediatric patient: case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Advances in the understanding of mast cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Activation of CD47 receptors causes histamine secretion from mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

G protein-dependent activation of mast cell by peptides and basic secretagogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Mastocytosis in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

21 January 2018

Paediatric mastocytosis

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Surrogate markers of disease in mastocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Presentation of cutaneous mastocytosis in 173 children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Mastocytosis: mediator-related signs and symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Anesthetic management of a labouring parturient with urticaria pigmentosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Acute stress-induced seizures and loss of consciousness in a ten-year-old boy with cutaneous mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Mast cell disease: surgical and anesthetic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Autism spectrum disorders and mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Anesthesia in children with mastocytosis--a case based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Mastocytosis: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Mast cell mediators in allergic inflammation and mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Contemporary challenges in mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Clinical aspects of diffuse cutaneous mastocytosis in children: two variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Altered Metabolism of Mast-Cell Growth Factor (c-kit Ligand) in Cutaneous Mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Mastocytosis and allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Are gastrointestinal mucosal mast cells increased in patients with systemic mastocytosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

On being metachromatic: mystique and misunderstanding in mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Diagnostic value of tryptase in anaphylaxis and mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Mastocytosis: pathology, genetics, and current options for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Systemic mastocytosis presenting as profound cardiovascular collapse during anaesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Massive histamine release in a patient with systemic mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Undiagnosed systemic mastocytosis in a teenager revealed during general anesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Re: Undiagnosed systemic mastocytosis in a teenager revealed during general anesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Mechanisms of activation of human mast cells and basophils by general anaesthetic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Perioperative anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Anaphylaxis during anaesthesia. Results of a two-year survey in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Anaesthetic management of systemic mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Mastocytosis: current treatment concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in vivo microdialysis study in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Histamine-release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Different patterns of mast cell activation by muscle relaxants in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Determination of the hemodynamics and histamine release of rocuronium (Org 9426) when administered in increased doses under N2O/O2-sufentanil anesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Large doses of vecuronium and plasma histamine concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Neuromuscular and cardiovascular effects of high-dose vecuronium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Histamine release during the induction of anesthesia with propofol in allergic patients: a comparison with the induction of anesthesia using midazolam-ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Anaesthesia in patients with mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Inhibition of the histamine-induced Ca2 influx in primary human endothelial cells (HUVEC) by volatile anaesthetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Lidocaine down-regulates nuclear factor-kappaB signalling and inhibits cytokine production and T cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Effect of lidocaine on histamine release and Ca2 mobilization from mast cells and basophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Paracetamol (acetaminophen) attenuates in vitro mast cell and peripheral blood mononucleocyte cell histamine release induced by N-acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Cutaneous mastocytosis in children: anaesthetic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Mastocytosis: current concepts in diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Fibrinolysis during anaphylaxis, and its spontaneous resolution, as demonstrated by thromboelastography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

An unusual cause of spontaneous bleeding in the intensive care unit - mastocytosis: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Mast cell tryptase in anaesthetic anaphylactoid reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

An unusual presentation of mastocytosis: unilateral swelling of the vulva

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00540-013-1563-2

Histamine Release by Narcotics and Muscle Relaxants in Humans

21 January 2018

2 references

https://api.crossref.org/works/10.1007/S00540-013-1563-2

21 January 2018

12 December 2020

Mastocytosis in children: a protocol for management

1 reference

12 December 2020

Incidence of histamine release after the administration of midazolam-ketamine in allergic patients

1 reference

12 December 2020

Heterogeneity of Human Mast Cells and Basophils in Response to Muscle Relaxants

1 reference

12 December 2020

Codeine-induced histamine release in intact human skin monitored by skin microdialysis technique: comparison ofintradermal injections with an atraumatic intraprobe drug delivery system

1 reference

12 December 2020

Histamine liberation by codeine and polymyxin B in urticaria pigmentosa

1 reference

12 December 2020

Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA)

1 reference

12 December 2020

Anaphylactic reaction after skin-prick testing in an 8-year-old boy

1 reference

12 December 2020

Histamine release by four narcotics: a double-blind study in humans

1 reference

12 December 2020

Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis

1 reference

12 December 2020

Onset time, endotracheal intubating conditions, and plasma histamine after cisatracurium and vecuronium administration

1 reference

12 December 2020

Pediatric cutaneous mastocytosis: a review of 180 patients.

1 reference

12 December 2020

The use of H1 and H2 histamine antagonists with morphine anesthesia: a double-blind study.

1 reference

12 December 2020

Anesthetic considerations in mastocytosis.

1 reference

12 December 2020

Absence of mast cell degranulation during general anesthesia in a child with mastocytosis

1 reference

12 December 2020

Determinants of in vivo histamine release in cutaneous allergic reactions in humans

1 reference

12 December 2020

[Evolution of plasma histamine after midazolam in patients at risk of histamine liberation]

1 reference

12 December 2020

General anesthesia in a child with urticaria pigmentosa

1 reference

12 December 2020

[Anesthesia of a child with a cutaneous mastocytosis]

1 reference

12 December 2020

Hemodynamics and Histamine Release during Induction with Sufentanil or Fentanyl

1 reference

12 December 2020

Familial urticaria pigmentosa associated with thrombocytosis as the initial symptom of systemic mastocytosis and Down's syndrome

1 reference

12 December 2020

Histamine concentrations and hemodynamic responses after remifentanil

1 reference

12 December 2020

Mastocytosis in infants and children: recognition of patterns of skin disease

1 reference

12 December 2020

Dental management of a pediatric patient with mastocytosis: a case report.

1 reference

12 December 2020

Comparison of mastocytosis with onset in children and adults

1 reference

12 December 2020

Infusion and bolus administration of cisatracurium--effects on histamine release.

1 reference

12 December 2020

IL-6 levels predict disease variant and extent of organ involvement in patients with mastocytosis

1 reference

12 December 2020

[Circulatory arrest in the course of anesthesia for a child with mastocytosis]

1 reference

12 December 2020

Monozygotic twins discordant for cutaneous mastocytosis

1 reference

12 December 2020

Overexpression of complement receptors and related antigens on the surface of bone marrow mast cells in patients with systemic mastocytosis

1 reference

12 December 2020

Anesthetic management in a pediatric patient with Noonan syndrome, mastocytosis, and von Willebrand disease: a case report

1 reference

12 December 2020

Recurrent syncope due to systemic mastocytosis

1 reference

12 December 2020

HEREDITARY URTICARIA PIGMENTOSA

1 reference

12 December 2020

The flush syndrome: an expression of systemic mastocytosis with increased prostaglandin D2 production

1 reference

12 December 2020

Guidelines for safe surgery in patients with systemic mastocytosis.

1 reference

12 December 2020

10.1007/S00540-013-1563-2

Identifiers

DOI

1 reference

28 August 2017

1 reference